Indaptus Therapeutics Inc
NASDAQ:INDP
Indaptus Therapeutics Inc
NASDAQ:INDP
Price:
2.02 USD
0.75%
Market Closed
Updated:
May 5, 2024
Indaptus Therapeutics Inc
Cash from Investing Activities
|
Indaptus Therapeutics Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Indaptus Therapeutics Inc
NASDAQ:INDP
|
Cash from Investing Activities
$17.1m
|
CAGR 3-Years
184%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Indaptus Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
17.1m
USD
17.1m
USD
Based on the financial report for Dec 31, 2023, Indaptus Therapeutics Inc's Cash from Investing Activities amounts to 17.1m USD.
What is Indaptus Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
184%
184%
The average annual Cash from Investing Activities growth rates for Indaptus Therapeutics Inc have been 184% over the past three years .
You don't have any saved screeners yet
